Loading…

Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building--May-October 2013

On September 9, 2013, the Hawaii Department of Health (HDOH) was notified of seven patients with severe acute hepatitis and fulminant liver failure of unknown etiology. Patients were previously healthy and sought medical care during May-September 2013. Clinicians reported that the seven patients had...

Full description

Saved in:
Bibliographic Details
Published in:MMWR. Morbidity and mortality weekly report 2013-10, Vol.62 (40), p.817
Main Author: Centers for Disease Control and Prevention (CDC)
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 40
container_start_page 817
container_title MMWR. Morbidity and mortality weekly report
container_volume 62
creator Centers for Disease Control and Prevention (CDC)
description On September 9, 2013, the Hawaii Department of Health (HDOH) was notified of seven patients with severe acute hepatitis and fulminant liver failure of unknown etiology. Patients were previously healthy and sought medical care during May-September 2013. Clinicians reported that the seven patients had all used OxyELITE Pro, a dietary supplement marketed for weight loss and muscle gain, before illness onset.
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_24113901</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>24113901</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-9ced26522c90129f1e020d852384bdd8f6f3914bc462a4913ef7468582ccfc1d3</originalsourceid><addsrcrecordid>eNo1kN1KAzEQhRdBbK2-gswLBDY_u-56J8U_qPZGwbuSTSZtJLtZNomlT-OrmvozN4eB853hzEkxp5WoSFPT91lxHsJHeRxenhUzJijlbUnnxdeLjxjATL6HuEMwFp2-AalSRNjhKKONNoAcNDj7iRMYaV2astE75_d22P5gKSB4AxK0xSinA4Q0jg57HCLYIeKgUWdkgj3a7S6C8yFAXvsUlEPoknU6ZxHyLA9kraLv8ilWUn5RnBrpAl7-6aJ4u797XT6S1frhaXm7IiNldSStQs3qijGVW7HWUCxZqZuK8UZ0WjemNrylolOiZlK0lKO5FnVTNUwpo6jmi-LqN3dMXY96M062zz02_5_i35mNZgg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building--May-October 2013</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>PubMed Central</source><creator>Centers for Disease Control and Prevention (CDC)</creator><creatorcontrib>Centers for Disease Control and Prevention (CDC)</creatorcontrib><description>On September 9, 2013, the Hawaii Department of Health (HDOH) was notified of seven patients with severe acute hepatitis and fulminant liver failure of unknown etiology. Patients were previously healthy and sought medical care during May-September 2013. Clinicians reported that the seven patients had all used OxyELITE Pro, a dietary supplement marketed for weight loss and muscle gain, before illness onset.</description><identifier>EISSN: 1545-861X</identifier><identifier>PMID: 24113901</identifier><language>eng</language><publisher>United States</publisher><subject>Acute Disease ; Adolescent ; Adult ; Aged ; Dietary Supplements - adverse effects ; Female ; Hawaii ; Hepatitis - etiology ; Humans ; Liver Failure - chemically induced ; Male ; Middle Aged ; Muscle Strength ; Weight Loss ; Young Adult</subject><ispartof>MMWR. Morbidity and mortality weekly report, 2013-10, Vol.62 (40), p.817</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24113901$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Centers for Disease Control and Prevention (CDC)</creatorcontrib><title>Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building--May-October 2013</title><title>MMWR. Morbidity and mortality weekly report</title><addtitle>MMWR Morb Mortal Wkly Rep</addtitle><description>On September 9, 2013, the Hawaii Department of Health (HDOH) was notified of seven patients with severe acute hepatitis and fulminant liver failure of unknown etiology. Patients were previously healthy and sought medical care during May-September 2013. Clinicians reported that the seven patients had all used OxyELITE Pro, a dietary supplement marketed for weight loss and muscle gain, before illness onset.</description><subject>Acute Disease</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Dietary Supplements - adverse effects</subject><subject>Female</subject><subject>Hawaii</subject><subject>Hepatitis - etiology</subject><subject>Humans</subject><subject>Liver Failure - chemically induced</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Muscle Strength</subject><subject>Weight Loss</subject><subject>Young Adult</subject><issn>1545-861X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNo1kN1KAzEQhRdBbK2-gswLBDY_u-56J8U_qPZGwbuSTSZtJLtZNomlT-OrmvozN4eB853hzEkxp5WoSFPT91lxHsJHeRxenhUzJijlbUnnxdeLjxjATL6HuEMwFp2-AalSRNjhKKONNoAcNDj7iRMYaV2astE75_d22P5gKSB4AxK0xSinA4Q0jg57HCLYIeKgUWdkgj3a7S6C8yFAXvsUlEPoknU6ZxHyLA9kraLv8ilWUn5RnBrpAl7-6aJ4u797XT6S1frhaXm7IiNldSStQs3qijGVW7HWUCxZqZuK8UZ0WjemNrylolOiZlK0lKO5FnVTNUwpo6jmi-LqN3dMXY96M062zz02_5_i35mNZgg</recordid><startdate>20131011</startdate><enddate>20131011</enddate><creator>Centers for Disease Control and Prevention (CDC)</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20131011</creationdate><title>Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building--May-October 2013</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-9ced26522c90129f1e020d852384bdd8f6f3914bc462a4913ef7468582ccfc1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acute Disease</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Dietary Supplements - adverse effects</topic><topic>Female</topic><topic>Hawaii</topic><topic>Hepatitis - etiology</topic><topic>Humans</topic><topic>Liver Failure - chemically induced</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Muscle Strength</topic><topic>Weight Loss</topic><topic>Young Adult</topic><toplevel>online_resources</toplevel><creatorcontrib>Centers for Disease Control and Prevention (CDC)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>MMWR. Morbidity and mortality weekly report</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><aucorp>Centers for Disease Control and Prevention (CDC)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building--May-October 2013</atitle><jtitle>MMWR. Morbidity and mortality weekly report</jtitle><addtitle>MMWR Morb Mortal Wkly Rep</addtitle><date>2013-10-11</date><risdate>2013</risdate><volume>62</volume><issue>40</issue><spage>817</spage><pages>817-</pages><eissn>1545-861X</eissn><abstract>On September 9, 2013, the Hawaii Department of Health (HDOH) was notified of seven patients with severe acute hepatitis and fulminant liver failure of unknown etiology. Patients were previously healthy and sought medical care during May-September 2013. Clinicians reported that the seven patients had all used OxyELITE Pro, a dietary supplement marketed for weight loss and muscle gain, before illness onset.</abstract><cop>United States</cop><pmid>24113901</pmid></addata></record>
fulltext fulltext
identifier EISSN: 1545-861X
ispartof MMWR. Morbidity and mortality weekly report, 2013-10, Vol.62 (40), p.817
issn 1545-861X
language eng
recordid cdi_pubmed_primary_24113901
source JSTOR Archival Journals and Primary Sources Collection; PubMed Central
subjects Acute Disease
Adolescent
Adult
Aged
Dietary Supplements - adverse effects
Female
Hawaii
Hepatitis - etiology
Humans
Liver Failure - chemically induced
Male
Middle Aged
Muscle Strength
Weight Loss
Young Adult
title Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building--May-October 2013
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A20%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Notes%20from%20the%20field:%20acute%20hepatitis%20and%20liver%20failure%20following%20the%20use%20of%20a%20dietary%20supplement%20intended%20for%20weight%20loss%20or%20muscle%20building--May-October%202013&rft.jtitle=MMWR.%20Morbidity%20and%20mortality%20weekly%20report&rft.aucorp=Centers%20for%20Disease%20Control%20and%20Prevention%20(CDC)&rft.date=2013-10-11&rft.volume=62&rft.issue=40&rft.spage=817&rft.pages=817-&rft.eissn=1545-861X&rft_id=info:doi/&rft_dat=%3Cpubmed%3E24113901%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p126t-9ced26522c90129f1e020d852384bdd8f6f3914bc462a4913ef7468582ccfc1d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/24113901&rfr_iscdi=true